William Blair analyst Sharon Zackfia reiterated a Buy rating on Portillo’s today. The company’s shares opened today at $9.64. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...

King Charles may want to revive contact with Harry, and perhaps see his grandchildren Lilibet and Archie, one last time before he dies.

Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per ...

Shares of Fortinet were down as much as 27.4% in Thursday action, which would have made for their worst performance on record, though they ended down 22%. That finish marked the stock's steepest ...

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...

Shares of Fortinet were off 25.7% in afternoon trading Thursday. That could mark their worst one-day slide on record if losses of such magnitude hold through the close. Opinion: AI bots aren't just ...

BellRing Brands, Inc. (NYSE:BRBR) is one of the top oversold NYSE stocks to buy now. William Blair analyst Jon Andersen ...

CBIZ, Inc. (NYSE:CBZ) is one of the top oversold NYSE stocks to buy now. On July 24, William Blair analyst Andrew Nicholas ...

Sarepta did not hold an investor call for its second-quarter earnings report or provide an updated full-year revenue outlook.

Discover Corpay's Q2 2025 earnings performance—13% revenue growth, strategic M&A updates, and a focus on Corporate Payments.

Crawford & Company ® (NYSE: CRD-A and CRD-B) is pleased to announce that the Company will take part in the 2025 William Blair Insurance, Banking & Wealth Technology Virtual Conference on Tu 12, 2025.

Contineum Therapeutics has pumped the brakes on two projects, freeing up resources to go full speed ahead in its pursuit of Bristol Myers Squibb in idiopathic pulmonary fibrosis.